Botulinum toxin type A-induced changes in the chemical coding of dorsal root ganglion neurons supplying the porcine urinary bladder.

  title={Botulinum toxin type A-induced changes in the chemical coding of dorsal root ganglion neurons supplying the porcine urinary bladder.},
  author={Agnieszka Bossowska and Mariusz Krzysztof Majewski},
  journal={Polish journal of veterinary sciences},
  volume={15 2},
Botulinum toxin type A (BTX) is a potent neurotoxin, which in recent years has been effectively applied in experimental treatments of many neurogenic disorders of the urinary bladder. BTX is a selective, presynaptically-acting blocking agent of acetylcholine release from nerve terminals what, in turn, leads to the cessation of somatic motor and/or parasympathetic transmission. However, application of this toxin in urological practice is still in the developmental stages and the full mechanism… 

Tables from this paper

Botulinum Toxin Type A Induces Changes in the Chemical Coding of Substance P-Immunoreactive Dorsal Root Ganglia Sensory Neurons Supplying the Porcine Urinary Bladder

It is demonstrated that BTX significantly modifies the chemical phenotypes of SP-IR BPSN, a bladder-projecting sensory neurons (BPSN) after the toxin treatment.

The Botulinum Toxin as a Therapeutic Agent: Molecular Structure and Mechanism of Action in Motor and Sensory Systems.

The structure and mechanism of actions of BoNT on motor and sensory neurons to explain its therapeutic effects and future potential are summarized.

The Influence of Tetrodotoxin (TTX) on the Distribution and Chemical Coding of Caudal Mesenteric Ganglion (CaMG) Neurons Supplying the Porcine Urinary Bladder

The present study is the first to suggest that TTX modifies the chemical coding of CaMG neurons supplying the porcine urinary bladder after intravesical instillation of tetrodotoxin (TTX).

Effect of Bladder Injection of OnabotulinumtoxinA on the Central Expression of Genes Associated with the Control of the Lower Urinary Tract: A Study in Normal Rats

Findings suggest that bladder injections of OnabotulinumtoxinA may be followed by changes in the expression of sensory, sympathetic and cholinergic bladder function regulators at the DRG/SC level.

The Influence of an Adrenergic Antagonist Guanethidine (GUA) on the Distribution Pattern and Chemical Coding of Dorsal Root Ganglia (DRG) Neurons Supplying the Porcine Urinary Bladder.

Evidence is provided that GUA significantly modifies the sensory innervation of the porcine urinary bladder wall and thus may be considered a potential tool for studying the plasticity of this subdivision of the bladder innervation.

Therapeutic use of botulinum toxin in pain treatment

  • Raj Kumar
  • Biology, Medicine
    Neuronal signaling
  • 2018
Evidence suggests that botulinum toxin can also affect central nervous system (CNS), which holds great potential for pain treatments.

Botulinum neurotoxin type A: Actions beyond SNAP-25?

BoNT/A in the Urinary Bladder—More to the Story than Silencing of Cholinergic Nerves

The current evidence of BoNT/A’s effect on bladder sensation, potential mechanisms by which it might exert these effects and recent advances in understanding the action ofBoNT in bladder tissue are presented.



Effect of botulinum toxin A on the autonomic nervous system of the rat lower urinary tract.

The data indicate that the clinical effects of botulinum toxin A on the lower urinary tract may vary depending on the site of injection and level of nerve activity.

Sensitivity of embryonic rat dorsal root ganglia neurons to Clostridium botulinum neurotoxins.

Drug Insight: biological effects of botulinum toxin A in the lower urinary tract

These effects on sensory feedback loops might not only help to explain the mechanism of BTX-A in relieving symptoms of overactive bladder, but also suggest a potential role for BTX -A in the relief of hyperalgesia associated with lower urinary tract disorders.

Distribution and neurochemical characterization of sensory dorsal root ganglia neurons supplying porcine urinary bladder.

A novel description of both spatial and neurochemical organization pattern of porcine urinary bladder sensory innervation constitutes a basis for further functional studies aimed at unraveling neurogenic mechanisms of urinary bladder diseases.

Botulinum toxin type a inhibits calcitonin gene-related peptide release from isolated rat bladder.

Intravesical botulinum toxin a administration produces analgesia against acetic acid induced bladder pain responses in rats.

Intravesical BTX administration blocked acetic acid induced bladder pain responses and inhibited CGRP release from afferent nerve terminals and these results support the clinical application of BTX-A for the treatment of interstitial cystitis and other types of visceral pain.

Botulinum A toxin effects on rat jaw muscle spindles.

The Botox effect on muscle spindles suggests that the relief from dystonias could be due not only to a partial motor paralysis, but also to a decrease of the reflex muscular tone.

Expression of neuropeptides and nitric oxide synthase in neurones innervating the inflamed rat urinary bladder.

Decreased sensory receptors P2X3 and TRPV1 in suburothelial nerve fibers following intradetrusor injections of botulinum toxin for human detrusor overactivity.

Investigation of a possible effect of BoNT/A on human bladder afferent mechanisms by studying the sensory receptors P2X3 and TRPV1 in biopsies from patients with neurogenic or idiopathic DO found decreased levels of sensory receptors may contribute to the clinical effect ofBoNT/B in detrusor overactivity.